Pre-clinical safety studies of intranasal virus-like particles based vaccine for prevention of COVID-19

Pre-clinical safety studies of intranasal virus-like particles based vaccine for prevention of COVID-19

Introduction. The large-scale and prolonged pandemic of the novel coronavirus disease (COVID-19) has demonstrated the need for effective vaccination. Along with immunogenicity, safety is a critical issue for vaccines, as public trust can contribute to the success or failure of immunization programs....

Full description

Saved in:
Bibliographic Details
Main Authors: Yana Y. Chernoryzh, Valeria M. Kondratieva, Аnastasia P. Malkova, Tatyana E. Savochkina, Olesya V. Eliseeva, Oleg E. Latyshev, Dmitriy Y. Yakunin, Olga N. Zaykova, Ekaterina S. Sludnyakova, Tatyana V. Grebennikova
Format: Article
Language:English
Published: Central Research Institute for Epidemiology 2025-03-01
Series:Вопросы вирусологии
Subjects:
sars-cov-2
covid-19
virus-like particles
intranasal vaccines
safety
toxity
Online Access:https://virusjour.crie.ru/jour/article/viewFile/16701/935
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items